The sequential treatment of phenformin and mTOR inhibitors strikingly led to a dramatic improvement in the survival of orthotopic xenograft mice of human hepatocellular carcinoma (HCC) [33]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.